Literature DB >> 23384448

Acitretin affects bioenergetics of liver mitochondria and promotes mitochondrial permeability transition: potential mechanisms of hepatotoxicity.

Filomena S G Silva1, Mariana P C Ribeiro, Maria S Santos, Petronila Rocha-Pereira, Alice Santos-Silva, José B A Custódio.   

Abstract

Acitretin is a synthetic retinoid used for severe extensive psoriasis and it has been shown to be an effective and a safe therapeutic drug for other diseases including cancer when used in combination with other agents. However, cases of acitretin-associated liver injury have been documented, but the possible mechanisms of acitretin-associated hepatotoxicity and apoptosis are not entirely clarified. This study reports that mitochondrial dysfunctions may play an important role in liver injury and apoptosis induced by this retinoid. Acitretin (5-20 μM) impaired mitochondrial phosphorylation efficiency as demonstrated by the decrease in the state 3 respiration and ATP levels, and by the increase in the lag phase of ADP phosphorylation cycle, without affecting the membrane potential. Acitretin induced Ca(2+)-mediated mitochondrial permeability transition (MPT) and decreased the adenine nucleotide translocase (ANT) content. Acitretin-induced MPT was not prevented by thiol group protecting and antioxidant agents, excluding the involvement of oxidative stress mechanisms. However, MPT was prevented by ANT ligands ATP, ADP, tamoxifen and 4-hydroxytamoxifen, implying that the MPT induction by acitretin is mediated by the ANT. ANT plays a major role in promoting apoptosis and ATP synthesis, and it is still considered as a structural component of the pore with a regulatory role in MPT formation. Therefore, our results, including the decrease in the state 3 respiration and the increase in the lag phase of phosphorylation cycle, the ATP depletion and the induction of Ca(2+)-mediated MPT, indicate that acitretin-associated liver toxicity and apoptosis is possibly related with mitochondrial dysfunctions due to interactions with the ANT. Additionally, the combination of acitretin with other drugs, such as antiestrogens, which are able to inhibit the MPT, may contribute to decrease the toxicity induced by acitretin.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23384448     DOI: 10.1016/j.tox.2013.01.020

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  6 in total

Review 1.  Non-alcoholic fatty liver disease and psoriasis: So far, so near.

Authors:  Giulia Ganzetti; Anna Campanati; Annamaria Offidani
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Vitamin A and Retinoids as Mitochondrial Toxicants.

Authors:  Marcos Roberto de Oliveira
Journal:  Oxid Med Cell Longev       Date:  2015-05-19       Impact factor: 6.543

3.  Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy.

Authors:  Ploysyne Rattanakaemakorn; Prinpat Pinyowiwat; Wimolsiri Iamsumang; Kumutnart Chanprapaph; Poonkiat Suchonwanit
Journal:  Drug Des Devel Ther       Date:  2021-05-28       Impact factor: 4.162

4.  Acute high-altitude hypoxic brain injury: Identification of ten differential proteins.

Authors:  Jianyu Li; Yuting Qi; Hui Liu; Ying Cui; Li Zhang; Haiying Gong; Yaxiao Li; Lingzhi Li; Yongliang Zhang
Journal:  Neural Regen Res       Date:  2013-11-05       Impact factor: 5.135

Review 5.  Liver Illness and Psoriatic Patients.

Authors:  Marco Fiore; Sebastiano Leone; Alberto Enrico Maraolo; Emilio Berti; Giovanni Damiani
Journal:  Biomed Res Int       Date:  2018-02-06       Impact factor: 3.411

6.  Biocompatible Gold Nanoparticles Ameliorate Retinoic Acid-Induced Cell Death and Induce Differentiation in F9 Teratocarcinoma Stem Cells.

Authors:  Sangiliyandi Gurunathan; Jin-Hoi Kim
Journal:  Nanomaterials (Basel)       Date:  2018-06-01       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.